Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 10/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.53 |
| ▸ | MEN1 | O00255 | 6/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | DAO | P14920 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 7/20 | 0.43 |
| ▸ | RAB9A | P51151 | 6/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.42 |
| ▸ | TP53 | P04637 | 5/20 | 0.42 |
| ▸ | HTT | P42858 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL27553763 | 1.00 | GAA (0.53) | GAAHSD17B10MEN1KMT2AALDH1A1 | |
| SCHEMBL199861 | 1.00 | GAA (0.53) | GAAHSD17B10MEN1KMT2AALDH1A1 | |
| SCHEMBL41619 | 1.00 | GAA (0.53) | GAAHSD17B10MEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL11389456 | 0.98 | GAA (0.51) | GAAHSD17B10MEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL9474549 | 0.98 | GAA (0.51) | GAAHSD17B10MEN1KMT2AALDH1A1 | |
| Glycine SCHEMBL28074279 | 0.91 | ALDH1A1 (0.46) | GAAHSD17B10MEN1KMT2AALDH1A1 | |
| Dl-Phenylalanine SCHEMBL28266480 | 0.84 | SLC7A5 (0.58) | HPGDPTGS1PKM | |
| SCHEMBL10625398 | 0.84 | GAA (0.51) | GAAHSD17B10MEN1KMT2AALDH1A1 | |
| SCHEMBL8817575 | 0.84 | GAA (0.51) | GAAHSD17B10MEN1KMT2AALDH1A1 | |
| SCHEMBL10625410 | 0.84 | GAA (0.51) | GAAHSD17B10MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9460 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144842-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TRYPTOPHAN AND PHYLLOKININ DERIVATIVE FOR USE IN TREATING PSYCHIATRIC AND PSYCHOLOGICAL CONDITIONS | TEMPLE OTORONGO LLC (US) | 2026-05-28 | — | — | US | claimed |
| CN-122070295-A | Insect neuropeptide analogs | 索拉斯塔生物有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122070296-A | Insect neuropeptide analogs | 索拉斯塔生物有限公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4637801-A1 | POLYPEPTIDES | The University Court Of The University Of Glasgow (GB) | 2025-10-29 | — | — | EP | claimed |
| EP-4619043-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETED COMPOUNDS AND USE THEREOF | Perspective Therapeutics, Inc. (US) | 2025-09-24 | — | — | EP | claimed |
| US-12358948-B2 | Neurotensinergic agonists and methods of using same preventing or treating pain | SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) | 2025-07-15 | — | — | US | claimed |
| WO-2025128149-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETED COMPOUNDS AND USE THEREOF | VIEWPOINT MOLECULAR TARGETING, INC. (US) | 2025-06-19 | — | — | WO | claimed |
| US-20250186539-A2 | METHODS FOR TREATING CANCER | BICYCLETX LIMITED (GB) | 2025-06-12 | — | — | US | claimed |
| US-20250186630-A1 | FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES | VIEWPOINT MOLECULAR TARGETING, INC. (US) | 2025-06-12 | — | — | US | claimed |
| WO-2025088318-A1 | INSECT NEUROPEPTIDE ANALOGUES | Solasta Bio Limited (GB) | 2025-05-01 | — | — | WO | claimed |
| EP-0331404-A2 | Method for producing tropane alkaloid | SEITAIKINOU RIYOU KAGAKUHIN SHINSEIZOUGIJUTSU KENKYU KUMIAI (JP) | 1989-09-06 | — | — | EP | claimed |
| US-4861755-A | Peptides with vasorelaxant, natriuretic and diuretic effects a process for their preparation, agents containing them, and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-08-29 | — | — | US | claimed |
| EP-0326974-A1 | Amino acid amides with a psychotropic activity, processes for their preparation, compositions containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-08-09 | — | — | EP | claimed |
| EP-0288965-A2 | Peptides with a phospholipase A2 inhibiting activity | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-11-02 | — | — | EP | claimed |
| CN-87102304-A | Pharmaceutical preparation containing compounds with antidementia effect and its application in preventing and treating cognitive dysfunction | — | 1987-12-30 | — | — | CN | claimed |
| EP-0243645-A2 | Compounds having a nootropic activity, agents containing them and their use in the treatment and prophylaxis of cognitive malfunctions | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-11-04 | — | — | EP | claimed |
| EP-0239874-A2 | Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their application | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-10-07 | — | — | EP | claimed |
| EP-0230242-A2 | Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-07-29 | — | — | EP | claimed |
| EP-0225386-A1 | BRADYKININ ANTAGONIST PEPTIDES | NOVA TECHNOLOGY LIMITED PARTNERSHIP (US) | 1987-06-16 | — | — | EP | claimed |
| WO-1986007263-A1 | BRADYKININ ANTAGONIST PEPTIDES | STEWART JOHN M | 1986-12-18 | — | — | WO | claimed |